S. Oltra

Insight updating of the molecular hallmarks in ovarian carcinoma

2020EJC supplements : EJC : official journal of EORTC, European Organization for Research and Treatment of Cancer ... [et al.]15 citations Open access

Semantic Scholar

S. Oltra

Most-cited papers

Distinct GSDMB protein isoforms and protease cleavage processes differentially control pyroptotic cell death and mitochondrial damage in cancer cells

MicroRNA profile in very young women with breast cancer

Methylation deregulation of miRNA promoters identifies miR124-2 as a survival biomarker in Breast Cancer in very young women

Sex-specific genetic effects associated with pigmentation, sensitivity to sunlight, and melanoma in a population of Spanish origin

Low miR200c expression in tumor budding of invasive front predicts worse survival in patients with localized colon cancer and is related to PD-L1 overexpression

Genomic Profiling of Uterine Aspirates and cfDNA as an Integrative Liquid Biopsy Strategy in Endometrial Cancer

Role of cfDNA and ctDNA to improve the risk stratification and the disease follow-up in patients with endometrial cancer: towards the clinical application

Intratumor genetic heterogeneity and clonal evolution to decode endometrial cancer progression

HDAC5 Inhibitors as a Potential Treatment in Breast Cancer Affecting Very Young Women

Loxl3 Promotes Melanoma Progression and Dissemination Influencing Cell Plasticity and Survival

Breast Cancer in Very Young Patients in a Spanish Cohort: Age as an Independent Bad Prognostic Indicator

miR302a and 122 are deregulated in small extracellular vesicles from ARPE-19 cells cultured with H2O2

Noninvasive detection of microsatellite instability in patients with endometrial cancer

Acceleration in the DNA methylation age in breast cancer tumours from very young women

Insight updating of the molecular hallmarks in ovarian carcinoma

Isoform-specific function of calpains in cell adhesion disruption: studies in postlactational mammary gland and breast cancer.

Modeling MC1R rare variants: a structural evaluation of variants detected in a Mediterranean case-control study.

Predictive Role of Leptin Receptor (Ob-R) Overexpression in Patients with Early Breast Cancer Receiving Neoadjuvant Systemic Treatment

RUNAT-BI: A Ruthenium(III) Complex as a Selective Anti-Tumor Drug Candidate against Highly Aggressive Cancer Cell Lines

Sex-specific genetic effects associated with pigmentation, sensitivity to sunlight, and melanoma in a population of Spanish origin

miRNA Expression Analysis: Cell Lines HCC1500 and HCC1937 as Models for Breast Cancer in Young Women and the miR-23a as a Poor Prognostic Biomarker

30PDifferential microRNA expression in breast cancer patients aged 35 years or younger

Sun exposure and PDZK1 genotype modulate PDZK1 gene expression in normal skin

Pathway deregulation networks in breast cancer young patients: Own data with METABRIC and TCGA databases

FGFR1 drives metabolic adaptation associated with temozolomide resistance in glioblastoma.

FGFR1 inhibition improves therapy efficacy and prevents metabolic adaptation associated with temozolomide resistance in glioblastoma

Distinct GSDMB protein isoforms and protease cleavage processes differentially control pyroptotic cell death and mitochondrial damage in cancer cells

Hereditary Risk Assessment for BRCA Breast and/or Ovarian Cancer

PO-157 Estimation of functional effector genes reveals disease mechanisms in breast cancer in very young women

Younger age as a prognostic indicator in breast cancer: Correlation between clinical-pathologic factors and miRNAs and long-term follow-up

146 Molecular characterization of breast cancer cell lines from young women

184 Involvement of calpains in cell migration in different breast cancer cell lines

Title : MicroRNA profile in very young women with Breast Cancer

Modelling MC 1 R rare variants : A structural evaluation of variants detected in a Mediterranean case-control study